State Laws and Prescription Drug Abuse
州法律和处方药滥用
基本信息
- 批准号:9224453
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-30 至 2018-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
About 6.3% of the US population (ages 12+) have misused prescription (Rx) drugs in the past year,
with this prevalence almost double among young adults ages 18-25. Unintentional poisoning deaths involving
opioid pain relievers (Rx drugs most likely to be abused) have more than quadrupled from 1999-2010, and now
outnumber deaths from heroin and cocaine combined. Deaths related to Rx drug poisoning surpassed motor
vehicle crashes as the leading cause of injury-related mortality in 2009. The increase in the use of opioid pain
relievers is due in part to the liberalization of laws governing the prescription of opioid analgesics for chronic
pain, the introduction of new and more aggressive pain management standards, and the availability of new
drugs. This project will estimate the effects of key state initiatives targeting Rx drug abuse. These include
mandatory prescription drug monitoring programs (PDMP), an ID requirement at the dispensing stage, and
required physical exam of the patient prior to prescribing. For most states participation by prescribers and
dispensers in the PDMP is voluntary, and hence PDMP utilization rates are quite low and well below 50%.
Furthermore, there is very limited research on the effects of these policies despite recommendations by the
Obama administration and many state health departments to institute these programs. In addition to
addressing this knowledge gap, this project will also assess whether these policies have had unintended
consequences in terms of raising heroin use, which has more than doubled among young adults over the past
5 years. Among illicit drug users, Rx abuse is second in prevalence only to marijuana, and 1 out of 4 new illicit
drug users began their habit with non-medical use of Rx drugs. Thus, unintended consequences in the form of
greater use of heroin or other illicit drugs may occur as availability of Rx drugs is reduced by state programs.
Alternatively, positive spillovers are also possible if the number of individuals who acquire an opioid addiction
and consequently transition to heroin or other illicit drugs is reduced. Five complementary data sets will be
utilized to investigate these policy effects across a range of self-reported and objectively measured Rx and
illicit drug-use and drug-related health outcomes. Considerable variation in the adoption of these initiatives
across and within states, including staggered adoption of different policies within the same state, will be
exploited within a difference-in-differences (DD) research design to identify credible causal effects. The
models will be supplemented with various checks and sensitivity analyses, including testing and adjusting for
the assumptions underlying the DD estimation, assessing reinforcement effects across the policies, assessing
cumulative effects, assessing cross-border spillovers, and assessing heterogeneous policy responses. The
proposed research will provide the most comprehensive study to date of the effectiveness and possible
unintended consequences of key state initiatives aimed at curbing Rx drug diversion. These estimates will yield
valuable evidence informing policymakers on the mix of regulations effective in reducing Rx abuse.
项目摘要
约6.3%的美国人口(12岁以上)在过去一年中滥用处方药。
在18-25岁的年轻人中,这一发病率几乎翻了一番。意外中毒死亡涉及
阿片类止痛药(最有可能被滥用的处方药物)在1999-2010年间增加了四倍多,现在
死亡人数超过了海洛因和可卡因死亡人数的总和。与Rx药物中毒有关的死亡人数超过摩托车
2009年,车祸是与伤害有关的死亡的主要原因。阿片类疼痛使用量的增加
缓解的部分原因是管理阿片类止痛药处方的法律放开
疼痛,引入新的和更积极的疼痛管理标准,以及新的
毒品。该项目将评估针对Rx药物滥用的关键国家倡议的影响。这些措施包括
强制性处方药监测计划(PDMP),配药阶段的ID要求,以及
在开药前必须对患者进行体检。对于大多数州来说,处方医生和
PDMP中的配送器是自愿的,因此PDMP的使用率相当低,远远低于50%。
此外,关于这些政策的影响的研究非常有限,尽管
奥巴马政府和许多州卫生部门制定了这些计划。除了……之外
为了解决这一知识差距,该项目还将评估这些政策是否有无意的
在提高海洛因使用量方面的后果,过去年轻人的海洛因使用量增加了一倍多
五年了。在非法吸毒者中,Rx滥用的流行率仅次于大麻,每四个新的非法药物中就有一个
吸毒者开始他们的习惯,非医疗使用Rx药物。因此,以下形式的意外后果
随着国家计划减少Rx药物的供应,海洛因或其他非法药物的使用可能会更多。
或者,如果染上阿片成瘾的个人数量增加,积极的溢出效应也是可能的
从而减少了向海洛因或其他非法药物的过渡。五个互补的数据集将是
用于调查一系列自我报告和客观测量的Rx和
非法药物使用和与药物有关的健康后果。在采用这些倡议方面有相当大的差异
跨州和州内,包括在同一州内交错采用不同的政策,将是
在差异性(DD)研究设计内利用,以确定可信的因果关系。这个
模型将补充各种检查和敏感度分析,包括测试和调整
DD估计的基础假设,评估政策的加固效果,评估
累积效应,评估跨境溢出效应,以及评估不同的政策反应。这个
拟议的研究将提供迄今为止最全面的有效性和可能的研究
旨在遏制Rx药物转移的关键国家举措的意外后果。这些估计将产生
有价值的证据为政策制定者提供了有效减少Rx滥用的法规组合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Henry Saffer其他文献
Henry Saffer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Henry Saffer', 18)}}的其他基金
The Effects of New E-cigarette Internet Sales Bans and E-cigarette Flavor Bans on Tobacco Use by Youth, Young Adults and Adults
新的电子烟互联网销售禁令和电子烟口味禁令对青少年、年轻人和成年人使用烟草的影响
- 批准号:
10594564 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
The Effects of New E-cigarette Internet Sales Bans and E-cigarette Flavor Bans on Tobacco Use by Youth, Young Adults and Adults
新的电子烟互联网销售禁令和电子烟口味禁令对青少年、年轻人和成年人使用烟草的影响
- 批准号:
10449651 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Alcohol Taxes, Alcohol Prices and Alcohol Sales: Quasi-Natural Experiments
酒精税、酒精价格和酒精销售:准自然实验
- 批准号:
9763399 - 财政年份:2018
- 资助金额:
$ 5万 - 项目类别:
Prescription Prices and Direct to Consumer Advertising
处方价格和直接面向消费者的广告
- 批准号:
7288366 - 财政年份:2006
- 资助金额:
$ 5万 - 项目类别:
相似海外基金
Scaling laws for aerodynamics of moving wings in the Martian atmosphere
火星大气中动翼空气动力学的标度定律
- 批准号:
DP240100294 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Discovery Projects
Collaborative Research: DASS: Empirically Evaluating Data Fiduciary Privacy Laws
合作研究:DASS:实证评估数据信托隐私法
- 批准号:
2317115 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Collaborative Research: Identifying Hydrogen-Density Based Laws for Plasticity in Polycrystalline Materials
合作研究:确定基于氢密度的多晶材料塑性定律
- 批准号:
2303108 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
RFA-CE-23-006, Do state alcohol-related firearm laws reduce mortality? A multicomponent impact evaluation
RFA-CE-23-006,各州与酒精相关的枪支法是否会降低死亡率?
- 批准号:
10791372 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Collaborative Research: SaTC: TTP: Medium: Defending the Supply Chain of Democracy: Towards a Cryptographically Verified and Authenticated Network of Laws
合作研究:SaTC:TTP:媒介:捍卫民主供应链:迈向经过密码验证和认证的法律网络
- 批准号:
2247829 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
CDS&E/Collaborative Research: A Symbolic Artificial Intelligence Framework for Discovering Physically Interpretable Constitutive Laws of Soft Functional Composites
CDS
- 批准号:
2244952 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Physical laws to control and regulate composition of multi-component biomolecular condensates
控制和调节多组分生物分子凝聚物成分的物理定律
- 批准号:
10713887 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Ensuring the Effectiveness of Anti-Discrimination Laws and Self-Examination Affirmative Action
确保反歧视法和自查平权行动的有效性
- 批准号:
23KJ0320 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Laws and Realities of Cooperation and Sharing in the Middle East: Partnership and Property Sharing
中东合作共享的法律与现实:合伙与财产共享
- 批准号:
23H00748 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Collaborative Research: EAGER: MedAn: A Framework for Investigating Live Medical Data against Privacy Laws
合作研究:EAGER:MedAn:根据隐私法调查实时医疗数据的框架
- 批准号:
2335686 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Continuing Grant